ArticleOncology letters2017

Chemotherapy regimen based on sorafenib combined with 5-FU on HIF-1α and VEGF expression and survival in advanced gastric cancer patients.

Ronghui Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.